Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2013 2
2014 1
2016 1
2017 3
2018 3
2020 4
2021 11
2022 18
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean greco den hartog (7 results)?
Serological profiling of pneumococcal proteins reveals unique patterns of acquisition, maintenance and waning of antibodies throughout life.
He SWJ, Voß F, Nicolaie MA, Brummelman J, van de Garde MDB, Bijvank E, Poelen M, Wijmenga-Monsuur AJ, Wyllie AL, Trzciński K, Van Beek J, Rots NY, den Hartog G, Hammerschmidt S, van Els CACM. He SWJ, et al. Among authors: den hartog g. J Infect Dis. 2024 Apr 29:jiae216. doi: 10.1093/infdis/jiae216. Online ahead of print. J Infect Dis. 2024. PMID: 38679601
IgG1 glycosylation highlights premature aging in Down syndrome.
Streng BMM, Van Coillie J, Wildenbeest JG, Binnendijk RS, Smits G, den Hartog G, Wang W, Nouta J, Linty F, Visser R, Wuhrer M, Vidarsson G, Bont LJ; PRIDE study group. Streng BMM, et al. Among authors: den hartog g. Aging Cell. 2024 Apr 15:e14167. doi: 10.1111/acel.14167. Online ahead of print. Aging Cell. 2024. PMID: 38616780 Free article.
Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands.
Verheul MK, Kaczorowska J, Hofstee MI, Schepp RM, Smits GP, Wessels Beljaars D, Kuijer M, Schuin W, Middelhof I, Wong D, van Hagen CCE, Vos ERA, Nicolaie MA, de Melker HE, van Binnendijk RS, van der Klis FRM, den Hartog G. Verheul MK, et al. Among authors: den hartog g. Mucosal Immunol. 2024 Mar 27:S1933-0219(24)00027-8. doi: 10.1016/j.mucimm.2024.03.008. Online ahead of print. Mucosal Immunol. 2024. PMID: 38553008 Free article.
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose.
Roozen GVT, Prins MLM, Prins C, Janse JJ, de Gruyter HLM, Pothast CR, Huisman W, Koopman JPR, Lamers OAC, Kuijer M, Myeni SK, van Binnendijk RS, Hartog GD, Heemskerk MHM, Jochems SP, Feltkamp MCW, Kikkert M, Rosendaal FR, Roestenberg M, Visser LG, Roukens AHE. Roozen GVT, et al. Among authors: hartog gd. Clin Microbiol Infect. 2024 Mar 28:S1198-743X(24)00159-9. doi: 10.1016/j.cmi.2024.03.028. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 38552793 Free article.
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.
Prins MLM, Roozen GVT, Pothast CR, Huisman W, van Binnendijk R, den Hartog G, Kuiper VP, Prins C, Janse JJ, Lamers OAC, Koopman JPR, Kruithof AC, Kamerling IMC, Dijkland RC, de Kroon AC, Azimi S, Feltkamp MCW, Kuijer M, Jochems SP, Heemskerk MHM, Rosendaal FR, Roestenberg M, Visser LG, Roukens AHE. Prins MLM, et al. Among authors: den hartog g. NPJ Vaccines. 2024 Jan 2;9(1):1. doi: 10.1038/s41541-023-00785-w. NPJ Vaccines. 2024. PMID: 38167735 Free PMC article.
Effect of age and season on respiratory mucosal immune marker profiles.
van Woudenbergh E, van Rooijen DM, Veldman-Wolf JJ, Nicolaie MA, Huynen MA, van der Klis FRM, de Jonge MI, den Hartog G. van Woudenbergh E, et al. Among authors: den hartog g. J Allergy Clin Immunol. 2023 Dec 23:S0091-6749(23)02490-9. doi: 10.1016/j.jaci.2023.12.009. Online ahead of print. J Allergy Clin Immunol. 2023. PMID: 38142822 Free article.
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.
de Boer PT, van de Kassteele J, Vos ERA, van Asten L, Dongelmans DA, van Gageldonk-Lafeber AB, den Hartog G, Hofhuis A, van der Klis F, de Lange DW, Stoeldraijer L; RIVM COVID‐19 epidemiology and surveillance team; de Melker HE, Geubbels E, van den Hof S, Wallinga J. de Boer PT, et al. Among authors: den hartog g. Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37621921 Free PMC article.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
Hofsink Q, Haggenburg S, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, van Meerloo J, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Rots N, van Beek J, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI study team. Hofsink Q, et al. Among authors: den hartog g. EClinicalMedicine. 2023 Jul;61:102040. doi: 10.1016/j.eclinm.2023.102040. Epub 2023 Jun 15. EClinicalMedicine. 2023. PMID: 37337616 Free PMC article.
56 results